Global Coalition on Aging Partners with Canadian Organizations to Provide Vital Information Directly to Canada’s Caregivers on How and Why to Protect Themselves This Flu Season

The unique public education campaign highlights the difference between COVID-19 and influenza vaccines and opportunities to protect oneself against both viruses through a single visit to the doctor or pharmacy.

New York, NEW YORK and Ottawa, ONTARIO (September 27, 2022)—The Global Coalition on Aging (GCOA), Immunize Canada, and other leading organizations across Canada have partnered on a unique public education campaign highlighting the need and opportunity for Canada’s caregivers to protect themselves against influenza. The education campaign, which launched this month, features an infographic and sharable social media materials, in English and French, providing usable data about influenza and immunization directly to Canada’s 8 million caregivers.

The campaign highlights the danger that a case of influenza poses to caregivers and those in their care, information about the different influenza vaccines available in Canada, and convenient opportunities to fit vaccination against influenza into a caregiver’s already busy day, such as getting the vaccine at the same time as a COVID-19 booster.

In an average year, 20% of Canadians will become ill with influenza, leading to 12,000 hospitalizations alone and negative health impacts that extend far beyond a case of the flu.

“Few people realize that just having the flu increases your risk of a heart attack by six times and your risk of pneumonia by eight times. These kinds of catastrophic health impacts are particularly devastating to caregivers and their families,” explained Michael Hodin, CEO of the Global Coalition on Aging. “Further, the stress of the caregiver role can lead to even greater susceptibility to the flu. Vaccination against influenza is one important way that caregivers can safeguard their own health as well as those in their care,” said Hodin.

Yet most Canadian caregivers are unprotected. “Only 42% of Canadian adults age 18 and older received the vaccine during the two influenza seasons between 2018 and 2020,” said Dr. Anne Pham-Huy, Chair of Immunize Canada. “Data from Australia suggests that the 2022-2023 flu season may be particularly bad, making it even more important that Canadian caregivers receive their seasonal influenza vaccination.”

The education campaign materials were developed in consultation with more than a dozen organizations across Canada, from caregiver and patient organizations, to academic and research institutions and private sector experts. The materials are easily accessible and sharable via social media and available for public use.

For more information or to partner on this campaign, contact Susan Wile Schwarz at [email protected].

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Brazil Must Fight Antibiotic Resistance

The threat posed by antimicrobial resistance is urgent and spares no country - including Brazil. According to The Lancet, 63 deaths per 100,000 are associated with AMR in Brazil and Paraguay, a rate that exceeds the average for Latin America and the Caribbean. AMR-associated deaths in Brazil are second only to cardiovascular diseases and cancers.

We Missed 100 Million Adult Vaccines – Here’s How We Get Back on Track

Like other pandemics throughout human history, COVID-19 has caused profound changes that are still rippling through our societies, even as people are understandably eager to move on. In fact, these impacts are all the more dangerous when they are largely ignored or effectively invisible. The decline in adult vaccination may be one of the most significant, as a new report finds that ~100 million doses were missed in 2021 and 2022 alone – reversing global progress towards widespread adult immunisation as a new standard of care in a world of more old than young.

New Analysis Shows Lost Ground on Adult Immunisation During the Pandemic with 100 Million Doses Potentially Missed

New data shared today by GSK, in collaboration with the IQVIA Institute for Human Data Science and the Global Coalition on Aging (GCOA), estimate approximately 100 million fewer doses of some adult vaccines (excluding Covid-19 vaccines) were administered in 2021 and 2022 than anticipated, based on the global vaccination adoption trends observed from 2013 to 2020, compounding already low adoption rates pre-pandemic.

Going Beyond Applause: The Potential of Caregiving to Unlock Job Opportunities of the Future

Early in the COVID-19 pandemic, the role of caregivers – staff and family who provide care for older and dependent people to carry out activities such as eating or moving - catapulted to the front of our collective conscience. The daily applause for front-line care workers showed a high level of recognition for their incredible work and provided insight into how our health systems must change as our society ages. We need to continue to recognise caregivers as essential to our ageing society.

High-Level Forum on the Silver Economy 2023

Join us for the High-Level Forum on the Silver Economy 2023. Now in its fourth year, the Silver Economy Forum 2023, December 6 and 7, will explore aging at every stage of life, looking at the growing global Silver Economy through a multigenerational lens. Linking to the goals and aspirations of the UN Decade of Healthy Ageing, SEF 2023 will highlight key themes at the intersection of aging at every age, and the Silver Economy.

Global Coalition on Aging Workshop Calls on G7 Countries to Fund Pull Incentives to Spur Antibiotic Innovation

The Global Coalition on Aging, in partnership with JPMA, today announced the release of its workshop report on the AMR crisis facing G7 countries and the world, “The Value of Pull Incentives in Japan to Encourage Investment in Antibiotic Innovation to Solve the AMR Crisis.” If strong action is not taken to address AMR, we will lose the antibiotics we need to cure infections, which is likely to outpace cancer as a major cause of death, killing an estimated 10 million by 2050.